Company Nico Laboratories Medical Srl with Fiscal Code 34215853
recorded a turnover of 2024 of
58.755,
with a net profit of
22.705
and having an average number of employees of
2.
The company operates in the field of Alte activitati referitoare la sanatatea umana having the NACE code 8690.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Nico Laboratories Medical Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
11.712
3.394
3.425
354.624
222.387
30.558
31.149
44.759
233.737
58.755
Total Income - EUR
11.712
3.394
3.425
354.624
222.387
30.558
31.149
44.760
233.739
58.757
Total Expenses - EUR
8.940
4.337
6.658
9.308
16.347
16.903
177.312
107.627
33.805
34.324
Gross Profit/Loss - EUR
2.772
-943
-3.233
345.316
206.040
13.655
-146.163
-62.868
199.934
24.433
Net Profit/Loss - EUR
2.420
-1.045
-3.337
341.665
203.816
13.364
-146.474
-63.306
197.644
22.705
Employees
1
1
1
1
1
1
1
1
1
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -74.7%, from 233.737 euro in the year 2023, to 58.755 euro in 2024.
The Net Profit decreased by -173.834 euro, from 197.644 euro in 2023, to 22.705 in the last year.
Check the financial reports for the company - Nico Laboratories Medical Srl
Financial Rating - NICO LABORATORIES MEDICAL SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Nico Laboratories Medical Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Nico Laboratories Medical Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Nico Laboratories Medical Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Nico Laboratories Medical Srl - CUI 34215853
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
0
0
0
0
0
0
0
0
0
0
Current Assets
6.249
5.849
2.403
346.918
544.603
522.981
367.018
305.338
363.462
318.181
Inventories
1.910
2.141
229
1.871
219
727
1.360
650
774
621
Receivables
3.937
2.917
1.926
340.415
530.326
489.090
303.504
199.833
354.092
305.983
Cash
402
791
247
4.633
14.058
33.164
62.153
104.855
8.596
11.578
Shareholders Funds
2.470
1.400
-1.961
339.740
536.977
518.406
360.435
298.247
356.549
309.522
Social Capital
49
49
48
47
46
52
51
51
51
50
Debts
3.780
4.449
4.363
7.178
7.626
4.575
6.583
7.091
6.913
8.660
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"8690 - 8690"
CAEN Financial Year
8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
318.181 euro in 2024 which includes Inventories of
621 euro, Receivables of
305.983 euro and cash availability of
11.578 euro.
The company's Equity was valued at
309.522 euro, while total Liabilities amounted to
8.660 euro.
Equity decreased by -45.034 euro, from 356.549 euro in 2023, to 309.522 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Nico Laboratories Medical Srl